BioStem Technologies, Inc. BSEM
1.15 USD 0.00 (+0.00%)
At close·Nov 4, 2026, 9:16 AM EST
1.20 +0.05 +4.35%
Pre-market · Nov 4, 9:16 AM ET
Day range unavailable
- YTD
- -69.82%
- 1 year
- -73.74%
Altman Z-Score
-3.33 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
P/E -9.8×
P/S 1.3×
P/B 1.6×
P/FCF 9.7×
EV/EBITDA -122×
EV/Sales 0.8×
FCF Yield 10.3%
Gross Margin 93.1%
Operating Margin -1.5%
Net Margin -13.9%
ROE -16.8%
ROIC -1.6%
ROA -13.2%
Revenue -84.3%
Operating Income -102.2%
EPS (diluted) -126.5%
Free Cash Flow -72.6%
Current Ratio 4.1×
Quick Ratio 3.9×
Debt / Equity 0.1×
Net Debt / EBITDA 85.1×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31